A major concern during and/or after an interventional procedure is an ischemic events1. Antiplatelet therapy is used to mitigate this risk by reducing platelet reactivity. However, up to a third of your patients may not be receiving the benefits from the antiplatelet medications given to prevent ischemic events.1
Studies have shown that patients who are not responding adequately to their antiplatelet therapy may be at approximately 5 to 10 times greater risk of MI, stent thrombosis and death.2-5
Assessing response to antiplatelet therapy should be easy.
it is.
Backed by numerous peer-reviewed studies that demonstrate clinical utility and analytical performance, the VerifyNow System provides you with an easy and rapid solution to help you assess your patient’s response to the following antiplatelet medications:
Click here to learn why you should join the growing number of interventional cardiologists who utilize the VerifyNow System to improve their patient care. 
- Dupont, AG. et al. Antiplatelet therapies and the role of antiplatelet resistance in acute coronary syndrome. Thromb Res. 2009 May;124(1):6-13.
- Patti, G. et al. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention. Results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of Myocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study. J Am Coll Cardiol. 2008; 52:1128–33.
- Marcucci, R. et al. Cardiovascular death and nonfatal myocardial Infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay. A 12-Month follow-Up. Circulation. 2009;119(2):237-42.
- Cuissett, T. et al. Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris. Am J Cardiol;2008 Jun 15:101(12):1700-3.
- Price, MJ. et al. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J. 2008 Apr;29(8):992-1000.
- Buonamici, P. et al. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol. 2007;49(24):2312-7.
